Table 1b:

Characteristics of Participants by Frequency of Artificially Sweetened Beverage Consumption- Medical Comorbidities

		Frequency of Artificially Sweetened Beverage Consumption
	Overall	Never or <1 serving /week	1–6 serving/week	≥1 serving/day
	80,388	51,480	18,414	10,494
	N (%)	N (%)	N (%)	N (%)	P-value
Treated Diabetes	4,390 (5.5)	1,804 (3.5)	1,450 (7.9)	1,136 (10.8)	<.001
Missing	75	51	11	13
Treated Hypertension	28,655 (36.0)	17,611 (34.6)	6,975 (38.3)	4,069 (39.1)	<.001
Missing	786	516	184	86
History of MI	2,202 (2.7)	1,342 (2.6)	537 (2.9)	323 (3.1)	0.006
Missing
History of CHF	1,192 (1.5)	675 (1.3)	312 (1.7)	205 (2.0)	<.001
Missing
Hormone Therapy use
Never used	26,654 (33.2)	17,685 (34.4)	5,691 (30.9)	3,278 (31.2)	<.001
Past user	11,198 (13.9)	7,354 (14.3)	2,471 (13.4)	1,373 (13.1)
Current user	42,519 (52.9)	26,429 (51.4)	10,250 (55.7)	5,840 (55.7)
Missing	17	12	2	3
Diuretic medication use (current)	14,059 (18.4)	8,426 (17.2)	3,499 (20.1)	2,134 (21.6)	<.001
Missing	4,157	2,547	980	630

Data expressed as N (%) unless otherwise indicated. P-value is chi-square for categorical variables and ANOVA for continuous variables. Measures were collected or updated to year 3.

CHF: congestive heart failure

MI: myocardial infarction